75782-77-3Relevant articles and documents
INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
-
, (2012/03/10)
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.
INHIBITION OF RAF KINASE USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
-
Page/Page column 9, (2008/06/13)
Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se,
INHIBITION OF RAF KINASE USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
-
Page/Page column 14-15, (2010/11/08)
Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.